Prime MedicineListed
primemedicine.combiotech_life_sciences
Prime Medicine is focused on transforming the lives of patients with debilitating diseases through its Prime Editing technology, a next-generation gene editing approach that aims…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Prime Medicine is focused on transforming the lives of patients with debilitating diseases through its Prime Editing technology, a next-generation gene editing approach that aims…
Developing transformative treatments using targeted in vivo delivery of tailored and long-lasting genetic medicines designed to overcome the limitations of today’s therapies.
Autobahn Therapeutics is focused on developing next-generation regenerative medicines for central nervous system (CNS) disorders, utilizing a brain-targeting chemistry platform to…
Metsera is a clinical-stage biotechnology company focused on engineering, developing, manufacturing, and commercializing a new generation of potent, ultra-long acting, scalable nu…
Orbital Therapeutics is pioneering RNA medicines designed to reset the immune system and restore health from within, focusing on autoimmune diseases, oncology, next-generation vac…
Magnet Biomedicine is advancing precision medicine with its modular TrueGlue™ technology, enabling the systematic discovery of molecular glues for treating human diseases, particu…
Eledon Pharmaceuticals is a clinical stage biotechnology company dedicated to developing immune-modulating therapies to protect transplanted organs and reduce the risk of organ re…
Exo Therapeutics is focused on unlocking intractable drug targets with exosites, utilizing their ExoSight™ platform to develop innovative therapeutic candidates primarily in oncol…
nChroma Bio is a genetic medicines company committed to addressing the limitations of existing therapies through a disease-first approach. By combining programmable in vivo delive…
Neumora Therapeutics focuses on developing precision medicines for brain diseases. They aim to address the unmet medical needs in neuroscience.
Details are not available yet. The company remains listed.
Aera Therapeutics is a biotechnology company leveraging its proprietary protein nanoparticle (PNP) delivery platform to unlock the full potential of genetic medicines. Aera’s plat…
Leal Therapeutics is developing novel, first-in-class, neuro-metabolic therapeutics for high unmet need CNS disorders, focusing on correcting key metabolic imbalances that underli…
CREATE Medicines is a clinical-stage biotech pioneering in vivo multi-immune programming. Its proprietary mRNA-LNP platform directly programs immune cells inside the body to deliv…